Selective macroautophagy serves as a vital pillar of the innate immune defense against viral pathogens. This process relies on specialized receptors to recognize viral components and shuttle them toward lysosomal degradation. However, a groundbreaking study has revealed a sophisticated method of coronavirus NSP5 autophagy evasion. Researchers discovered that the viral protease NSP5 targets the selective autophagy receptor CCDC50 to ensure viral survival and replication.

The Discovery of CCDC50 as an Antiviral Receptor

CCDC50 was previously characterized for its role in regulating interferon signaling. However, this recent research identifies it as a potent antiviral factor specifically targeting the porcine deltacoronavirus (PDCoV). The receptor recognizes the K63-linked polyubiquitinated envelope (E) protein of the virus. By binding to lysine 72 of the E protein, CCDC50 mediates its degradation through the autophagic pathway. Interestingly, this mechanism operates independently of well-known receptors such as SQSTM1/p62 and NBR1.

How Coronavirus NSP5 Autophagy Evasion Works

The virus has evolved a clever counter-strategy to protect its structural proteins. The NSP5 protease, which is essential for viral polyprotein processing, cleaves the CCDC50 receptor at a specific glutamine 171 (Q171) residue. This proteolytic cleavage is not limited to PDCoV. It is also a conserved feature among other coronaviruses, including SARS-CoV-2 and porcine epidemic diarrhea virus (PEDV). Consequently, coronavirus NSP5 autophagy evasion occurs because the cleavage prevents CCDC50 from interacting with ubiquitin and MAP1LC3/LC3. As a result, the viral envelope protein remains intact, facilitating productive infection.

Clinical Relevance and Future Perspectives

Understanding these molecular interactions provides a deeper insight into how coronaviruses subvert host immunity. Since the NSP5 cleavage site in CCDC50 is highly conserved across multiple coronavirus species, it represents a potential broad-spectrum therapeutic target. Inhibiting this specific cleavage could restore the host's natural ability to degrade viral proteins. Furthermore, this discovery emphasizes the critical role of selective autophagy in controlling zoonotic and human coronavirus outbreaks.

Frequently Asked Questions

What is the role of CCDC50 in coronavirus infection?

CCDC50 acts as a selective autophagy receptor. It recognizes the viral envelope protein and delivers it for lysosomal degradation to limit viral replication.

How does the NSP5 protease facilitate viral replication?

NSP5 cleaves the CCDC50 receptor at the Q171 site. This action disrupts the receptor's ability to link viral proteins to the autophagy machinery, allowing the virus to replicate unchecked.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding medical conditions. Refer to the latest local and national guidelines for clinical practice.

References

1. Li K et al. Coronavirus NSP5 protease cleaves CCDC50 to evade antiviral autophagy. Autophagy. 2026 Apr 11. doi: 10.1080/15548627.2026.2658847. PMID: 41964373.


2. Li K et al. PDCoV NSP5 cleaves the selective autophagy receptor CCDC50 to disrupt autophagic degradation of the viral envelope protein. mBio. 2026 Mar 12. doi: 10.1128/mbio.00259-26.


3. Hou P et al. A novel selective autophagy receptor, CCDC50, delivers K63 polyubiquitination-activated RIG-I/MDA5 for degradation during viral infection. Cell Res. 2021 Jan;31(1):62-79.